ArticleDiscover oncology2025
Identification of CCDC58 as a potential predictive biomarker of immune cell infiltration in hepatocellular carcinoma.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundMitochondrial dynamics play a critical role in the proper functioning of both the innate and adaptive immune systems. Coiled-coil domain-containing 58 (CCDC58), a mitochondrial-related gene, has been implicated in various diseases, including cancer and infections. However, its predictive value in immune cell infiltration in hepatocellular carcinoma (HCC) remains unexplored.
methodsIn this study, RNA-seq data from The Cancer Genome Atlas and multiple online datasets were analyzed to explore the correlation between CCDC58 and clinicopathological features, prognosis, related signaling pathways and immune cell infiltration in HCC. Furthermore, primary T cells were isolated and cell experiments such as cytotoxic assays and transwell assays were conducted to verify pivotal conclusions.
resultsWe found that CCDC58 expression levels were significantly increased in HCC tissues. High CCDC58 expression in HCC tissues was significantly correlated with the patients' TNM stage, histologic grade, AFP level, tumor status, and poor clinical outcomes. Furthermore, the high expression of CCDC58 conferred a decreased immune activated phenotype and poor immune cell infiltration, and was strongly associated with expression of immune cell exhaustion markers in HCC. After the knockdown of CCDC58 in HCC cell lines, we observed that cytotoxicity of primary T cells increased via decreasing PD-1 expression on T cells and migration ability of primary T cell enhanced.
conclusionOur study indicated that CCDC58 might serve as a potential predictive biomarker of immune cell infiltration in HCC and is correlated with poor prognosis in HCC patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.